[Therapeutic value of a new oral antidiabetic agent: gliclazide].
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D005907:Gliclazide / Q000627:therapeutic use*; D006029:Glycosuria; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D001786:Blood Glucose; D008055:Lipids; D013453:Sulfonylurea Compounds; D005907:Gliclazide
Valore terapeutico di un nuovo antidiabetico orale: la gliclazide.